Search

Results 1 - 10 of 40 Page 1 of 4
Results per-page: 10 | 20 | 50 | 100

Dementia Consortium

Relevance: 100%      Posted on: 26th February 2015

The Dementia Consortium will provide funding, resources and expertise to both increase the number of, and capitalise upon, new drug targets emerging from across the academic sector that hold promise of bringing patient benefit.

Dementia Consortium

Relevance: 100%      Posted on: 20th February 2015

The Dementia Consortium aims to expedite the development of new drugs for dementia by supporting research into novel targets for neurodegeneration. The progression of each application is assessed by the Dementia Consortium partners and by a panel of drug discovery experts associated with the MRCT Centre for Therapeutics Discovery. MRCT…

3m Dementia Consortium launched to boost dementia drug discovery

Relevance: 100%      Posted on: 10th December 2013

New Consortium unites charity, academic and private sectors in search for new treatments

Brain inflammation targeted in first drug discovery project from £3m Dementia Consortium

Relevance: 100%      Posted on: 19th June 2015

Funding worth nearly half a million pounds will unite academics at the University of Southampton with drug discovery experts at the medical research charity MRC Technology, to target the immune system in the hunt for new treatments for Alzheimer's disease. The work is the first to be funded by the…

Frontotemporal dementia targeted in new drug discovery project from the Dementia Consortium

Relevance: 100%      Posted on: 14th September 2015

The Dementia Consortium, a unique charity-private partnership between Alzheimer’s Research UK, MRC Technology and the pharmaceutical companies Eisai and Lilly, has invested £305,000 in a new project to identify drugs for frontotemporal dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). A team at the International Centre for Genetic Engineering and Biotechnology…

US team tackle immune system in £875,000 Dementia Consortium project

Relevance: 100%      Posted on: 1st March 2016

New dementia drug discovery efforts get underway this month at the University of South Florida, thanks to £875,000 funding from the Dementia Consortium. The US team of academics will work with drug development experts at UK-based MRC Technology, to target the immune system in a bid to halt nerve cell…

MSD joins £4.5 million Dementia Consortium

Relevance: 100%      Posted on: 8th March 2016

The Dementia Consortium has welcomed MSD (Merck & Co., Inc., Kenilworth, USA) as a new partner in their global venture to accelerate drug discovery for neurodegenerative disease. MSD is the latest pharmaceutical company to join the Dementia Consortium – a £4.5 million charity-industry partnership between Alzheimer’s Research UK, MRC Technology…

Dementia Consortium

Relevance: 100%      Posted on: 9th November 2017

This unique initiative unites charity, academic and private sectors in the search for new dementia treatments.

Dementia Consortium

Relevance: 100%      Posted on: 17th November 2017

The Dementia Consortium provides funding, expertise and resources for promising dementia research.

Dementia Consortium Roadshow

Relevance: 100%      Posted on: 17th August 2018

Find out more about how the Dementia Consortium can support you

Can't find what you're looking for?

Looking for dementia information - try our dementia section.

Involved in science? try Funding for scientists.

Contact us

Can we help you find what you're looking for? Is there anything else we can help you with? Get in touch.

Get in touch